Deziyangxin suppresses non-small cell lung cancer through remodeling of the tumor immune microenvironment
DZYX exerts anti-tumor activity in NSCLC associated with remodeling of the tumor immune microenvironment and multi-pathway molecular regulation. These findings provide mechanistic support for the traditional use of DZYX in tumor-related disorders and highlight its potential as an immunomodulatory candidate for lung cancer therapy.
Authors
- Si Lining
- Lhachen Tsering
- Bai Bobo
- Zhao Yanli
- Yi Yun
- Zhang Caifeng
- Li Peiqing
- Huang Shifa
- He Rongzhang
Institutions
- Qinghai University (CN)
- Qinghai University Affiliated Hospital (CN)
- Qinghai Tibetan Hospital (CN)
- Chenzhou First People's Hospital (CN)
- University of South China (CN)
Publication Details
- Journal
- Journal of Ethnopharmacology
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1016/j.jep.2026.121547
- Primary Topic
- Andrographolide Research and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00